You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR REZULIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for REZULIN

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003058 ↗	Troglitazone in Treating Patients With Liposarcoma	Completed	National Cancer Institute (NCI)	Phase 2	1997-06-01	Troglitazone may help liposarcoma cells develop into normal cells. This was a single arm, open-label study with a two-stage design to evaluate troglitazone in patients with liposarcoma stratified by histologic subtype.
NCT00003058 ↗	Troglitazone in Treating Patients With Liposarcoma	Completed	Dana-Farber Cancer Institute	Phase 2	1997-06-01	Troglitazone may help liposarcoma cells develop into normal cells. This was a single arm, open-label study with a two-stage design to evaluate troglitazone in patients with liposarcoma stratified by histologic subtype.
NCT01068860 ↗	To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies	Completed	Novartis	Phase 2	2010-02-01	This was a 10-week, placebo-controlled, randomized study to investigate the effect of injectable IL-1B antagonist, Canakinumab , in participants with impaired glucose tolerance or Type 2 Diabetes Mellitus (T2DM) already treated on different background diabetes therapies.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for REZULIN

Condition Name

Chart
Table

Condition Name for REZULIN
Intervention	Trials
Impaired Glucose Tolerance	1
Sarcoma	1
Type 2 Diabetes Mellitus	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for REZULIN
Intervention	Trials
Glucose Intolerance	1
Diabetes Mellitus, Type 2	1
Diabetes Mellitus	1
Sarcoma	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for REZULIN

Trials by Country

Map
Table

Trials by Country for REZULIN
Location	Trials
United States	8
India	7
Italy	7
Canada	2
Australia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for REZULIN
Location	Trials
Utah	1
Texas	1
Pennsylvania	1
North Dakota	1
Nebraska	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for REZULIN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for REZULIN
Clinical Trial Phase	Trials
Phase 2	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for REZULIN
Clinical Trial Phase	Trials
Completed	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for REZULIN

Sponsor Name

Chart
Table

Sponsor Name for REZULIN
Sponsor	Trials
National Cancer Institute (NCI)	1
Dana-Farber Cancer Institute	1
Novartis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for REZULIN
Sponsor	Trials
Industry	1
NIH	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.